0001437749-22-015773.txt : 20220623
0001437749-22-015773.hdr.sgml : 20220623
20220623194440
ACCESSION NUMBER: 0001437749-22-015773
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diamandis Peter
CENTRAL INDEX KEY: 0001528288
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 221036688
MAIL ADDRESS:
STREET 1: 4640 ADMIRALTY WAY
STREET 2: SUITE 500
CITY: MARINA DEL REY
STATE: CA
ZIP: 90292
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2021-11-15
2021-11-15
0001851657
Vaxxinity, Inc.
VAXX
0001528288
Diamandis Peter
1717 MAIN STREET
SUITE 3388
DALLAS
TX
75201
1
Class A common stock
2021-11-15
4
C
0
13824
A
13824
D
Class A common stock
2021-11-15
4
C
0
13824
A
13824
I
Held by spouse
Series A preferred stock
2021-11-15
4
C
0
21511
D
Class A common stock
13824
0
D
The Reporting Person unintentionally omitted this transaction from the Form 4 filed on November 15, 2021.
Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
The Reporting Person incorrectly reported that 271,655 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock. Instead, 13,824 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock.
These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest.
/s/ Rene Paula Molina, attorney-in-fact for Peter Diamandis
2022-06-23